Survey using a questionnaire
OtherPatient Preference Utility Assessment and Questionnaires
NCT Number: NCT07382583
To develop an educational tool to help patients and healthcare professionals make informed decisions about endometrial cancer and available prevention options for it (such as the use of a levonorgestrel-releasing intrauterine system [LNG-IUS]).
Interested in participating?
Request Info18 year and older
Female
Observational
MD Anderson Cancer Center, Houston, Texas, United States
Primary Objectives
The overall goal of this study is to create a personalized decision support educational tool for the use of LNG-IUS as a primary prevention strategy for women at risk of EC. The decision support tool will not replace the consultation with a clinician. Rather, it will help prepare the participant to better understand their options and prepare them for conversations with clinicians when making a decision about use of LNG-IUS. The primary objectives will be accomplished in two phases:
Phase 1 Primary Objective:
Phase 2 Primary Objective:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
This study will include participants from three categories: Unaffected women, Affected women, and Healthcare Providers. The eligibility criteria for each group are listed below:
Inclusion criteria
Exclusion criteria
Patient Preference Utility Assessment and Questionnaires
Time frame: Through study completion; an average of 1 year
Contact information is provided by the study sponsor or research team.
M.D. Anderson Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06840886
Adenocarcinoma, Adnexal Diseases
Beverly Hills, California, United States
View Trial DetailsNCT05640999
Endometrial Cancer, Endometrial Neoplasms
Anchorage, Alaska, United States
View Trial DetailsNCT06242470
Adenocarcinoma, Adnexal Diseases
Los Angeles, California, United States
View Trial DetailsNCT07041606
Endometrial Cancer, Endometrial Neoplasms
Arkhangelsk, Russia
View Trial Details